Patients with OPC with HPV-negative tumors have increased risk for head and neck cancer mortality.
HPV-positive sinonasal squamous cell carcinoma associated with improved overall survival.
Overall, 87.4 percent of 239 patients achieved negative margins with endoscopic resection.
Significant slowing found in rate of increase from 2009 to 2014, followed by stable rate since 2014.
[OncoTargets and Therapy] Researchers outline the case of a 93-year-old female with advanced ATC who received initial treatment with apatinib.
This review seeks to shed light on a relatively common but poorly understood adverse effect of radiotherapy for primary and metastatic brain or head and neck tumors.
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment.
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
From 2013 to 2014, incidence of HPV-positive oropharyngeal cancers was 4.62 per 100,000 persons.